Worth Venture Partners »

iShares Dow Jones US Medical Dev. shares owned by Worth Venture Partners

Quarter-by-quarter ownership of iShares Dow Jones US Medical Dev. (IHI) shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in iShares Dow Jones US Medical Dev.

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Medical Dev. held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Medical Dev. by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $908k 16k 58.59
2022-03-31 $969k 16k 60.94

More positions owned by Worth Venture Partners

Johnson & Johnson (JNJ)
Arteris (AIP)
Ishares Tr U.s. Med Dvc Etf (IHI)
Iteris (ITI)
Weave Communications (WEAV)
Shotspotter (SSTI)
Radcom Shs New (RDCM)
Cto Realty Growth (CTO)
Apellis Pharmaceuticals (APLS)
Insmed Com Par $.01 (INSM)
Sarepta Therapeutics Call Call Option
Novo-nordisk A S Adr (NVO)
Egain Corp Com New (EGAN)
Whitestone REIT (WSR)
Equity Comwlth Com Sh Ben Int (EQC)

View all positions for Worth Venture Partners

Top funds holding iShares Dow Jones US Medical Dev.

Citigroup
Morgan Stanley
Bank of America Corporation
LPL Financial
Fisher Investments
UBS Group
Wells Fargo & Company
Envestnet Asset Management
Royal Bank of Canada
Goldman Sachs Group
Jpmorgan Chase & Co
J Arnold Wealth Management
Citadel Advisors
Ameriprise Financial
Flaharty Asset Management

View all funds holding iShares Dow Jones US Medical Dev.